Literature DB >> 29446096

Degradation pattern of a porcine collagen membrane in an in vivo model of guided bone regeneration.

E Calciolari1,2, F Ravanetti3, A Strange4, N Mardas2, L Bozec4, A Cacchioli3, N Kostomitsopoulos5, N Donos1,2.   

Abstract

BACKGROUND AND
OBJECTIVE: Although collagen membranes have been clinically applied for guided tissue/bone regeneration for more than 30 years, their in vivo degradation pattern has never been fully clarified. A better understanding of the different stages of in vivo degradation of collagen membranes is extremely important, considering that the biology of bone regeneration requires the presence of a stable and cell/tissue-occlusive barrier during the healing stages in order to ensure a predictable result. Therefore, the aim of this study was to investigate the degradation pattern of a porcine non-cross-linked collagen membrane in an in vivo model of guided bone regeneration (GBR).
MATERIAL AND METHODS: Decalcified and paraffin-embedded specimens from calvarial defects of 18, 10-month-old Wistar rats were used. The defects were treated with a double layer of collagen membrane and a deproteinized bovine bone mineral particulate graft. At 7, 14 and 30 days of healing, qualitative evaluation with scanning electron microscopy and atomic force microscopy, and histomorphometric measurements were performed. Markers of collagenase activity and bone formation were investigated using an immunofluorescence technique.
RESULTS: A significant reduction of membrane thickness was observed from 7 to 30 days of healing, which was associated with progressive loss of collagen alignment, increased collagen remodeling and progressive invasion of woven bone inside the membranes. A limited inflammatory infiltrate was observed at all time points of healing.
CONCLUSION: The collagen membrane investigated was biocompatible and able to promote bone regeneration. However, pronounced signs of degradation were observed starting from day 30. Since successful regeneration is obtained only when cell occlusion and space maintenance exist for the healing time needed by the bone progenitor cells to repopulate the defect, the suitability of collagen membranes in cases where long-lasting barriers are needed needs to be further reviewed.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  collagen membrane; guided bone regeneration; histomorphometry; immunohistochemistry

Mesh:

Substances:

Year:  2018        PMID: 29446096     DOI: 10.1111/jre.12530

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  5 in total

1.  Cross-linked hyaluronic acid slows down collagen membrane resorption in diabetic rats through reducing the number of macrophages.

Authors:  Meizi Eliezer; Anton Sculean; Richard J Miron; Carlos Nemcovsky; Dieter D Bosshardt; Masako Fujioka-Kobayashi; Miron Weinreb; Ofer Moses
Journal:  Clin Oral Investig       Date:  2021-10-04       Impact factor: 3.573

2.  Photocrosslinkable Col/PCL/Mg composite membrane providing spatiotemporal maintenance and positive osteogenetic effects during guided bone regeneration.

Authors:  Feilong Wang; Dandan Xia; Siyi Wang; Ranli Gu; Fan Yang; Xiao Zhao; Xuenan Liu; Yuan Zhu; Hao Liu; Yongxiang Xu; Yunsong Liu; Yongsheng Zhou
Journal:  Bioact Mater       Date:  2021-11-03

3.  Effects on Tissue Integration of Collagen Scaffolds Used for Local Delivery of Gentamicin in a Rat Mandible Defect Model.

Authors:  Caroline Billings; Austin J Bow; Steven D Newby; Robert L Donnell; Madhu Dhar; David E Anderson
Journal:  Bioengineering (Basel)       Date:  2022-06-24

4.  Alveolar ridge preservation with guided bone regeneration or socket seal technique. A randomised, single-blind controlled clinical trial.

Authors:  Neil D MacBeth; Nikolaos Donos; Nikos Mardas
Journal:  Clin Oral Implants Res       Date:  2022-06-22       Impact factor: 5.021

Review 5.  Barrier membranes: More than the barrier effect?

Authors:  Omar Omar; Ibrahim Elgali; Christer Dahlin; Peter Thomsen
Journal:  J Clin Periodontol       Date:  2019-06       Impact factor: 8.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.